510(k) Report

510(k) · Cleared

Cleared

Quasar Blue Light Therapy System

K072767510(k) TraditionalCleared Oct 15, 200717-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Silver Bay, LLC · GEX Powered Laser Surgical Instrument

Cleared on Oct 15, 2007 after a 17-day review. FDA’s file for it is a 510(k) statement, which names no predicate. 131 later devices descend from it.

Decided
Oct 15, 2007
Review
17 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
0

131 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2012: 1 descendant cleared2013: 1 descendant cleared2014: 2 descendants cleared2017: 3 descendants cleared2015: 4 descendants cleared2018: 6 descendants cleared2016: 4 descendants cleared2026: 20 descendants cleared2023: 12 descendants cleared2020: 1 descendant cleared2021: 8 descendants cleared2024: 14 descendants cleared2022: 10 descendants cleared2019: 3 descendants cleared2025: 41 descendants cleared20052010201520202025
  1. This deviceK072767 Quasar Blue Light Therapy SystemSilver Bay, LLC · 2007
  2. Descendant · cites it directly · 130 of its ownK093963 Quasar Blue Light Therapy SystemSilver Bay, LLC · 2010
  3. Descendant · 2 generations on · 125 of its ownK121435 Silkn BlueHome Skinovations, Ltd. · 2013
  4. Descendant · 2 generations on · 81 of its ownK131461 Lightstim for Acne/ Lightstim for Acne MiniLed Intellectual Properties, LLC · 2014
  5. Descendant · 2 generations on · 76 of its ownK111286 Quasar CalypsoSilver Bay, LLC · 2012
  6. Descendant · 3 generations on · 75 of its ownK162098 LED Phototherapy DeviceLi-Tek Electronic Technology Corporation · 2017

Showing 5 of 131 descendants. See all descendants

Descendants cleared per year

2010: 12012: 12013: 12014: 22015: 42016: 42017: 32018: 62019: 32020: 12021: 82022: 102023: 122024: 142025: 412026: 20
2010high 41 (2025) · low 0 (2011)2026

Most influential descendants

Showing 5 of 131 · See all
  • K093963Quasar Blue Light Therapy SystemSilver Bay, LLC · 2010 · cites it directly130descendants
  • K121435Silkn BlueHome Skinovations, Ltd. · 2013 · 2 generations on125descendants
  • K131461Lightstim for Acne/ Lightstim for Acne MiniLed Intellectual Properties, LLC · 2014 · 2 generations on81descendants
  • K111286Quasar CalypsoSilver Bay, LLC · 2012 · 2 generations on76descendants
  • K162098LED Phototherapy DeviceLi-Tek Electronic Technology Corporation · 2017 · 3 generations on75descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K072767Quasar Blue Light Therapy SystemSilver Bay, LLC2007—
+1K093963Quasar Blue Light Therapy SystemSilver Bay, LLC2010—
+2K121435Silkn BlueHome Skinovations, Ltd.2013—
+2K131461Lightstim for Acne/ Lightstim for Acne MiniLed Intellectual Properties, LLC2014—
+2K111286Quasar CalypsoSilver Bay, LLC2012—
+3K162098LED Phototherapy DeviceLi-Tek Electronic Technology Corporation2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201210
201310
201420
201540
201640
201730
201860
201930
202010
202180
2022100
2023120
2024140
2025410
2026200
FIG. 1 — Lineage of K072767, 2007–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it? (131)

See all 131

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K093963Quasar Blue Light Therapy SystemSilver Bay, LLC2010130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K093963 (Silver Bay, LLC, 2010) has gone furthest, with 130 descendants of its own.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

The Quasar Blue Light Therapy System is intended to provide photo therapeutic light to the body. The Quasar Blue Light Therapy System is generally indicated to treat dermatological conditions. The Quasar Blue Light Therapy System is specifically indicated to emit visible blue/violet light to treat moderate inflammatory acne vulgaris.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K072767: Quasar Blue Light Therapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072767

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026